What is the recommended dose of Prozac (fluoxetine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fluoxetine (Prozac) Dosing Recommendations

For most adults with major depression, start fluoxetine at 20 mg once daily in the morning, which is sufficient to obtain a satisfactory response in most cases. 1

Standard Adult Dosing for Depression

  • Initial dose: 20 mg once daily in the morning is the FDA-approved starting dose for major depressive disorder 1
  • The dose range is 20-80 mg/day, though 20 mg/day is adequate for most patients 1
  • If insufficient clinical improvement occurs after several weeks, consider increasing the dose 1
  • Doses above 20 mg/day can be given once daily (morning) or twice daily (morning and noon), with a maximum of 80 mg/day 1
  • Full therapeutic effect may be delayed until 4 weeks of treatment or longer 1

Alternative Low-Dose Strategy

For patients with panic disorder or those prone to activation side effects, start at 10 mg/day and increase to 20 mg/day after one week. 1, 2

  • Approximately 28% of patients cannot tolerate the full 20 mg dose, with half of these responding well to lower doses 2
  • Starting at 5-10 mg and titrating up over one week is particularly useful for patients with concurrent panic disorder, who are more likely to experience intolerable activation 2

Special Population Dosing

Elderly and Dementia Patients

  • For elderly patients with dementia and depression, start at 10 mg every other morning, with a maximum of 20 mg every morning 3
  • Fluoxetine is activating with a very long half-life and should generally be avoided in older adults due to greater risk of agitation and overstimulation 3
  • Lower or less frequent dosing should be used in elderly patients and those with hepatic impairment 1

Pediatric Patients (Children and Adolescents)

  • Start with 10 mg/day for one week, then increase to 20 mg/day 1
  • For lower weight children, 10 mg/day may be both the starting and target dose 1
  • Dose increases to 20 mg/day can be considered after several weeks if insufficient improvement occurs 1

Other Indications

Obsessive-Compulsive Disorder (OCD)

  • Adults: Start at 20 mg/day in the morning, with a recommended range of 20-60 mg/day (maximum 80 mg/day) 1
  • Adolescents and higher weight children: Start at 10 mg/day, increase to 20 mg/day after 2 weeks, with a range of 20-60 mg/day 1
  • Lower weight children: Start at 10 mg/day, with a recommended range of 20-30 mg/day 1

Bulimia Nervosa

  • The recommended dose is 60 mg/day administered in the morning, as only this dose was statistically superior to placebo 1
  • Titrate up to this target dose over several days for some patients 1

Panic Disorder

  • Start at 10 mg/day, then increase to 20 mg/day after one week 1
  • The most frequently administered dose in clinical trials was 20 mg/day 1
  • Maximum studied dose is 60 mg/day 1

Managing Relapse on Maintenance Therapy

If a patient relapses on fluoxetine 20 mg/day during long-term treatment, increase the dose to 40 mg/day. 4

  • In one study, 67% of patients who relapsed on 20 mg/day had full response to 40 mg/day, with an additional 17% showing partial response 4
  • Overall, 61% of patients maintained their response on the higher dose during follow-up 4

Important Clinical Considerations

Activation vs. Sedation

  • Fluoxetine is generally activating and may cause nervousness, anxiety, agitation, and insomnia, particularly at doses of 60 mg/day and above 5
  • Activation symptoms peak early in treatment and decline over time 5
  • Some patients experience sedation (somnolence, asthenia), which increases linearly up to 40 mg/day 5
  • Discontinuations due to activation or sedation are uncommon 5

Hepatic and Renal Impairment

  • Use lower or less frequent dosing in patients with hepatic impairment 1
  • Dosage adjustments for renal impairment are not routinely necessary 1

Drug Interactions

  • Fluoxetine inhibits CYP2D6 and other cytochrome P450 enzymes, increasing potential for drug interactions, though most are not clinically important 6
  • Allow at least 14 days after stopping an MAOI before starting fluoxetine 1
  • Allow at least 5 weeks after stopping fluoxetine before starting an MAOI due to its long half-life 1

References

Research

Use of low-dose fluoxetine in major depression and panic disorder.

The Journal of clinical psychiatry, 1993

Guideline

Fluoxetine Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fluoxetine: activating and sedating effects.

International clinical psychopharmacology, 1993

Research

Safety and side effect profile of fluoxetine.

Expert opinion on drug safety, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.